Covestor’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
5
-4
| -44% | – | ﹤0.01% | 2261 |
|
|
2025
Q1 | $0 | Buy |
9
+3
| +50% | – | ﹤0.01% | 2272 |
|
|
2024
Q4 | $0 | Buy |
6
+3
| +100% | – | ﹤0.01% | 2281 |
|
|
2024
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 2271 |
|
|
2024
Q2 | $0 | Sell |
3
-7
| -70% | – | ﹤0.01% | 2284 |
|
|
2024
Q1 | $0 | Buy |
10
+5
| +100% | – | ﹤0.01% | 2288 |
|
|
2023
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2194 |
|
|
2023
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2167 |
|
|
2023
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 2177 |
|
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2078 |
|
|
2022
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2114 |
|
|
2022
Q3 | $0 | Sell |
5
-1
| -17% | – | ﹤0.01% | 2050 |
|
|
2022
Q2 | $0 | Sell |
6
-2
| -25% | – | ﹤0.01% | 1949 |
|
|
2022
Q1 | $0 | Sell |
8
-2
| -20% | – | ﹤0.01% | 2143 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2148 |
|